Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Elexacaftor/tezacaftor/ivacaftor can be effective for people with cystic fibrosis with the 3849 gene variant

Elexacaftor/tezacaftor/ivacaftor can be effective for people with cystic fibrosis with the 3849 gene variant

Resource Type

CF Research News

Authors

Moshe Heching, Michal Shteinberg, Inbal Golan-Tripto, Galit Livnat-Levanon, Karin Yaacoby-Bianu, Liora Boehm Cohen, Guy Hazan, Liora Slomianski, Dario Prais, Huda Mussaffi, Joel Weinberg, Mordechai R Kramer

References

J Cyst Fibros. 2024 Dec 5:S1569-1993(24)01845-9. doi: 10.1016/j.jcf.2024.11.010.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

3849+10kbC->T variant [3]
CFTR modulators [4]
Elexacaftor [5]
Residual function variant [6]

Date

Thursday, December 5, 2024

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [7]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/elexacaftortezacaftorivacaftor-can-be-effective-people-cystic

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-24-00310R2_FINAL_Heching_050125.pdf [2] https://pubmed.ncbi.nlm.nih.gov/39643544/ [3] https://www.ecfs.eu/research-article-keywords/384910kbc-t-variant [4] https://www.ecfs.eu/research-article-keywords/cftr-modulators [5] https://www.ecfs.eu/research-article-keywords/elexacaftor [6] https://www.ecfs.eu/research-article-keywords/residual-function-variant [7] https://www.ecfs.eu/resource-guideline-type/other-guidelines